Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings (2022)
- Authors:
- Duarte, Sebastião Mauro Bezerra
- Stefano, José Tadeu
- Franco, Lucas Augusto Moysés
- Martins, Roberta C
- Moraes, Bruna Del Guerra de Carvalho
- Barbeiro, Denise Frediani
- Oliveira, Nathalia
- Neri, JuniaMarielle Teixeira Rodrigues
- Cogliati, Bruno
- Vanni, Denise Siqueira
- Sabino, Ester Cerdeira
- Carrilho, Flair José
- Oliveira, Cláudia Pinto Marques Souza de
- USP affiliated authors: BARBEIRO, DENISE FREDIANI - FM ; COGLIATI, BRUNO - FMVZ ; SABINO, ESTER CERDEIRA - FM ; CARRILHO, FLAIR JOSÉ - FM ; OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM ; STEFANO, JOSÉ TADEU - FM ; FRANCO, LUCAS AUGUSTO MOYSÉS - FM
- Unidades: FM; FMVZ
- DOI: 10.3390/ijms231810483
- Subjects: SUPLEMENTOS DIETÉTICOS; OBESIDADE; MICROBIOLOGIA MÉDICA; ENTEROBACTERIACEAE
- Keywords: gut microbiota; synbiotic supplementation; probiotics; prebiotics; ob/ob mice
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Molecular Sciences
- ISSN: 1422-0067
- Volume/Número/Paginação/Ano: v. 23, n. 18, art. 10483, p. 1-16, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DUARTE, Sebastião Mauro Bezerra et al. Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings. International Journal of Molecular Sciences, v. 23, n. 18, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms231810483. Acesso em: 11 fev. 2026. -
APA
Duarte, S. M. B., Stefano, J. T., Franco, L. A. M., Martins, R. C., Moraes, B. D. G. de C., Barbeiro, D. F., et al. (2022). Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings. International Journal of Molecular Sciences, 23( 18), 1-16. doi:10.3390/ijms231810483 -
NLM
Duarte SMB, Stefano JT, Franco LAM, Martins RC, Moraes BDG de C, Barbeiro DF, Oliveira N, Neri JMTR, Cogliati B, Vanni DS, Sabino EC, Carrilho FJ, Oliveira CPMS de. Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 18): 1-16.[citado 2026 fev. 11 ] Available from: https://doi.org/10.3390/ijms231810483 -
Vancouver
Duarte SMB, Stefano JT, Franco LAM, Martins RC, Moraes BDG de C, Barbeiro DF, Oliveira N, Neri JMTR, Cogliati B, Vanni DS, Sabino EC, Carrilho FJ, Oliveira CPMS de. Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 18): 1-16.[citado 2026 fev. 11 ] Available from: https://doi.org/10.3390/ijms231810483 - The combination of probiotics and prebiotics supplementation improves lipid metabolism, NAFLD and obesity in ob/ob mice
- Molecular Characterization of the Fecal Microbiome in Brazilian Obese NASH patients compared to lean healthy controls
- Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study
- Quantification of experimental liver fibrosis with a novel algorithm method based on statistical analysis of signals
- Ultrasonographic elastography improves early detection of hepatocellular carcinoma in an experimental model of non-alcoholic steatohepatitis
- Doppler assessment of hepatic veins in obese dogs with fatty liver disease and comparison with a rodent model
- 18F-FDG PET/CT as an assessment tool of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease development in experimental model
- Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
- Elastography and contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma in an experimental model of nonalcoholic steatohepatitis
- P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC
Informações sobre o DOI: 10.3390/ijms231810483 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
COB_173_3099667_R.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
